Biolase PE Ratio 2006-2021 | BIOL

Current and historical p/e ratio for Biolase (BIOL) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biolase PE ratio as of June 11, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Biolase PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-06-11 0.84 0.00
2021-03-31 0.84 $-0.46 0.00
2020-12-31 0.42 $-0.59 0.00
2020-09-30 0.28 $-0.65 0.00
2020-06-30 0.46 $-0.69 0.00
2020-03-31 0.38 $-0.75 0.00
2019-12-31 0.55 $-0.79 0.00
2019-09-30 0.94 $-0.99 0.00
2019-06-30 1.47 $-0.97 0.00
2019-03-31 2.38 $-1.03 0.00
2018-12-31 0.99 $-1.05 0.00
2018-09-30 2.07 $-0.97 0.00
2018-06-30 1.21 $-1.04 0.00
2018-03-31 2.03 $-1.40 0.00
2017-12-31 2.13 $-1.45 0.00
2017-09-30 3.01 $-1.55 0.00
2017-06-30 4.85 $-1.60 0.00
2017-03-31 6.75 $-1.30 0.00
2016-12-31 7.00 $-1.35 0.00
2016-09-30 8.75 $-1.25 0.00
2016-06-30 5.85 $-1.35 0.00
2016-03-31 6.55 $-1.65 0.00
2015-12-31 4.21 $-1.75 0.00
2015-09-30 4.50 $-1.90 0.00
2015-06-30 8.70 $-1.85 0.00
2015-03-31 10.10 $-2.10 0.00
2014-12-31 13.15 $-2.30 0.00
2014-09-30 12.45 $-2.20 0.00
2014-06-30 11.00 $-2.44 0.00
2014-03-31 12.05 $-1.99 0.00
2013-12-31 14.08 $-1.73 0.00
2013-09-30 9.47 $-1.28 0.00
2013-06-30 17.63 $-0.74 0.00
2013-03-31 19.51 $-0.63 0.00
2012-12-31 9.02 $-0.48 0.00
2012-09-30 8.25 $-0.91 0.00
2012-06-30 9.42 $-0.96 0.00
2012-03-31 13.02 $-0.81 0.00
2011-12-31 12.29 $-0.71 0.00
2011-09-30 14.20 $-0.38 0.00
2011-06-30 24.09 $-0.74 0.00
2011-03-31 22.60 $-1.38 0.00
2010-12-31 8.04 $-2.25 0.00
2010-09-30 5.38 $-2.57 0.00
2010-06-30 6.94 $-1.88 0.00
2010-03-31 8.96 $-0.64 0.00
2009-12-31 8.77 $-0.51 0.00
2009-09-30 10.38 $-1.24 0.00
2009-06-30 7.76 $-2.30 0.00
2009-03-31 4.11 $-2.62 0.00
2008-12-31 6.85 $-1.75 0.00
2008-09-30 8.68 $-0.96 0.00
2008-06-30 15.71 $-0.78 0.00
2008-03-31 14.20 $-1.10 0.00
2007-12-31 10.84 $-1.42 0.00
2007-09-30 31.42 $-1.01 0.00
2007-06-30 27.89 $-0.51 0.00
2007-03-31 44.70 $-0.78 0.00
2006-12-31 40.20 $-0.92 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.112B $0.023B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $71.370B 19.28
Align Technology (ALGN) United States $48.443B 106.46
McKesson (MCK) United States $30.927B 11.35
Laboratory Of America Holdings (LH) United States $25.501B 8.61
West Pharmaceutical Services (WST) United States $25.379B 59.38
AmerisourceBergen (ABC) United States $24.842B 14.31
Straumann Holding AG (SAUHF) Switzerland $23.596B 0.00
Cooper (COO) United States $18.425B 31.20
Cardinal Health (CAH) United States $17.412B 10.31
DENTSPLY SIRONA (XRAY) United States $14.424B 31.76
Henry Schein (HSIC) United States $11.056B 24.03
STAAR Surgical (STAA) United States $6.764B 327.80
CONMED (CNMD) United States $3.964B 59.76
SmileDirectClub (SDC) United States $3.774B 0.00
Patterson (PDCO) United States $3.475B 18.25
Merit Medical Systems (MMSI) United States $3.438B 34.30
Atrion (ATRI) United States $1.142B 37.05
Antares Pharma (ATRS) United States $0.746B 49.11
Retractable Technologies (RVP) United States $0.382B 8.58
Invacare (IVC) United States $0.290B 0.00
Milestone Scientific (MLSS) United States $0.146B 0.00
Pro-Dex (PDEX) United States $0.120B 30.28
Lifevantage (LFVN) United States $0.118B 8.63